GlucoTrack, Inc. Files 8-K: Material Agreement, Financial Obligations, Equity Sales
Ticker: GCTK · Form: 8-K · Filed: Jul 22, 2024 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $350,000, $500,000, $1.56 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
TL;DR
GlucoTrack filed an 8-K detailing a new material agreement, financial obligations, and equity sales on July 18th.
AI Summary
On July 18, 2024, GlucoTrack, Inc. entered into a material definitive agreement, likely related to financing or operations, as indicated by the filing of an 8-K. The company also reported on the creation of a direct financial obligation and unregistered sales of equity securities, suggesting recent financial activities and potential dilution.
Why It Matters
This filing indicates significant recent financial and contractual activity for GlucoTrack, Inc., which could impact its financial standing and shareholder value.
Risk Assessment
Risk Level: medium — The filing indicates material definitive agreements, financial obligations, and unregistered sales of equity, which can introduce financial risks and potential dilution.
Key Players & Entities
- GlucoTrack, Inc. (company) — Registrant
- July 18, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by GlucoTrack, Inc. on July 18, 2024?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What type of direct financial obligation was created by GlucoTrack, Inc.?
The filing states the creation of a direct financial obligation, but the specific terms and nature of this obligation are not detailed in the provided text.
When were the unregistered sales of equity securities by GlucoTrack, Inc. reported?
The filing reports on unregistered sales of equity securities, with the earliest event reported being July 18, 2024.
What is the former name of GlucoTrack, Inc.?
The former name of GlucoTrack, Inc. was Integrity Applications, Inc., with a date of name change on December 3, 2010.
Where is GlucoTrack, Inc. incorporated and what is its business address?
GlucoTrack, Inc. is incorporated in Delaware and its business address is 301 Rte 17 North, Suite 800, Rutherford, NJ 07070.
Filing Stats: 971 words · 4 min read · ~3 pages · Grade level 12 · Accepted 2024-07-22 08:15:24
Key Financial Figures
- $350,000 — es in the aggregate principal amount of $350,000 (the "Notes" and each a "Note"). The
- $500,000 — oss proceeds to the Company of at least $500,000 (excluding indebtedness converted in su
- $1.56 — price per share shall not be lower than $1.56. Upon the occurrence of an Event of D
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex10-1.htm (EX-10.1) — 43KB
- 0001493152-24-028635.txt ( ) — 268KB
- gctk-20240718.xsd (EX-101.SCH) — 3KB
- gctk-20240718_lab.xml (EX-101.LAB) — 33KB
- gctk-20240718_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Glucotrack, Inc. Date: July 22, 2024 By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer